CIBMTR Reporting Implementation Guide
0.1.12 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.12: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Profile: CIBMTR Additional Drugs in Peri-Transplant Period
Security Label:
code: anti-thymocyte globulin Injection
| Item[x] | Strength |
| anti-thymocyte globulin Injection | 50 milligram (Details: UCUM codemg = 'mg')/1 milliliter (Details: UCUM codemL = 'mL') |